BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2416676)

  • 41. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
    Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
    J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
    Gullo CA; Esser MT; Fuller CL; Lam Braciale V
    J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR; Koszinowski UH; Eichmann K; Melchers I
    J Immunol; 1989 Dec; 143(12):4238-43. PubMed ID: 2556481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2.
    Ohlén C; Bejarano MT; Grönberg A; Torsteinsdottir S; Franksson L; Ljunggren HG; Klein E; Klein G; Kärre K
    J Immunol; 1989 May; 142(9):3336-41. PubMed ID: 2468716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
    Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.
    Yang TH; Aosai F; Norose K; Ueda M; Yano A
    J Immunol; 1995 Jan; 154(1):290-8. PubMed ID: 7995948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
    Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
    Sidky YA; Borden EC
    Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL.
    Lee K; Takenaka H; Yoneda Y; Goto T; Sano K; Nakanishi M; Eguchi A; Okada M; Tashiro J; Sakurai K; Kubota T; Yoshida R
    Microbiol Immunol; 2004; 48(1):15-25. PubMed ID: 14734854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells.
    Bukowski JF; Welsh RM
    J Exp Med; 1985 Jan; 161(1):257-62. PubMed ID: 2578543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic T lymphocytes recognize and lyse chondrocytes under inflammatory, but not non-inflammatory conditions.
    Cohen ES; Bodmer HC
    Immunology; 2003 May; 109(1):8-14. PubMed ID: 12709012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes.
    Weigelin B; Friedl P
    Biochem Pharmacol; 2010 Dec; 80(12):2087-91. PubMed ID: 20849829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Free fatty acids inhibit cytotoxic T lymphocyte-mediated lysis of allogeneic target cells.
    Richieri GV; Kleinfeld AM
    J Immunol; 1990 Aug; 145(4):1074-7. PubMed ID: 2380550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-reactive target antigen in cell-mediated cytolysis of cells infected with a temperature-sensitive mutant of Sindbis virus.
    Wolcott JA; Wust CJ; Brown A
    J Gen Virol; 1985 May; 66 ( Pt 5)():1167-70. PubMed ID: 3873514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gamma interferon production and cytotoxicity of spleen cells from mice infected with Semliki Forest virus.
    Blackman MJ; Morris AG
    J Gen Virol; 1984 May; 65 ( Pt 5)():955-61. PubMed ID: 6327889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential target cell susceptibility to SFV-immune cytotoxic T-cells.
    Müllbacher A; King NJ
    Arch Virol; 1989; 107(1-2):97-109. PubMed ID: 2478109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.